DOCS vs. IMRX

Last updated Jun 13, 2026

DOCS (Doximity, Inc.) and IMRX (Immuneering Corporation) are both stocks. Both are in the Healthcare sector — DOCS in Health Information Services, IMRX in Biotechnology. Over the past 3 years, DOCS returned -14.86%/yr vs -24.01%/yr for IMRX. At a 0.17 correlation, their price movements are largely independent.

Performance

DOCS vs. IMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Doximity, Inc. (DOCS) and Immuneering Corporation (IMRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DOCS achieves a -54.74% return, which is significantly lower than IMRX's -36.32% return.

DOCS

• 1D: 0.10%
• 1M: -14.32%
• YTD: -54.74%
• 6M: -54.30%
• 1Y: -64.81%
• 3Y*: -14.86%
• 5Y*: —
• 10Y*: —

IMRX

• 1D: 1.70%
• 1M: -22.12%
• YTD: -36.32%
• 6M: -31.09%
• 1Y: 113.78%
• 3Y*: -24.01%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DOCS vs. IMRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
DOCS Doximity, Inc.	-54.74%	-17.06%	90.41%	-16.45%	-33.05%	-16.25%
IMRX Immuneering Corporation	-36.32%	199.09%	-70.07%	51.55%	-70.01%	-17.08%

Correlation

The correlation between DOCS and IMRX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021	0.17

The correlation between DOCS and IMRX shifts across timeframes, from 0.02 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap DOCS : $3.91B IMRX : $270.92M
EPS DOCS : $0.98 IMRX : -$293.00
PB Ratio DOCS : 4.11 IMRX : 0.00
Total Revenue (TTM) DOCS : $644.86M IMRX : $0.00
Gross Profit (TTM) DOCS : $574.54M IMRX : -$698.89K
EBITDA (TTM) DOCS : $245.76M IMRX : -$15.38B

Return for Risk

DOCS vs. IMRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCS

DOCS Risk / Return Rank: 5
DOCS Sharpe Ratio Rank: 2
DOCS Sortino Ratio Rank: 3
DOCS Omega Ratio Rank: 2
DOCS Calmar Ratio Rank: 9
DOCS Martin Ratio Rank: 8

IMRX

IMRX Risk / Return Rank: 75
IMRX Sharpe Ratio Rank: 72
IMRX Sortino Ratio Rank: 78
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 76
IMRX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCS vs. IMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Doximity, Inc. (DOCS) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	DOCS	IMRX	Difference
Sharpe ratio: Return per unit of total volatility	-1.20	0.92	-2.12
Sortino ratio: Return per unit of downside risk	-1.96	2.05	-4.01
Omega ratio: Gain probability vs. loss probability	0.72	1.29	-0.57
Calmar ratio: Return relative to maximum drawdown	-0.85	1.98	-2.84
Martin ratio: Return relative to average drawdown	-1.43	3.30	-4.73

DOCS vs. IMRX - Sharpe Ratio Comparison

The current DOCS Sharpe Ratio is -1.20, which is lower than the IMRX Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of DOCS and IMRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

DOCS vs. IMRX - Drawdown Comparison

The maximum DOCS drawdown since its inception was -82.35%, smaller than the maximum IMRX drawdown of -96.86%. Use the drawdown chart below to compare losses from any high point for DOCS and IMRX.

Drawdown Indicators

	DOCS	IMRX	Difference
Max Drawdown Largest peak-to-trough decline	-82.35%	-96.86%	+14.51%
Max Drawdown (1Y) Largest decline over 1 year	-76.03%	-57.67%	-18.36%
Max Drawdown (3Y) Largest decline over 3 years	-78.34%	-90.98%	+12.64%
Current Drawdown Current decline from peak	-80.36%	-87.24%	+6.88%
Average Drawdown Average peak-to-trough decline	-57.18%	-77.61%	+20.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	45.49%	34.56%	+10.93%

Volatility

DOCS vs. IMRX - Volatility Comparison

The current volatility for Doximity, Inc. (DOCS) is 29.57%, while Immuneering Corporation (IMRX) has a volatility of 33.75%. This indicates that DOCS experiences smaller price fluctuations and is considered to be less risky than IMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DOCS	IMRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.57%	33.75%	-4.18%
Volatility (6M) Calculated over the trailing 6-month period	44.93%	79.00%	-34.07%
Volatility (1Y) Calculated over the trailing 1-year period	54.14%	124.22%	-70.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	70.07%	114.45%	-44.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.07%	114.45%	-44.38%

Dividends

DOCS vs. IMRX - Dividend Comparison

Neither DOCS nor IMRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both DOCS and IMRX in my portfolio?

DOCS and IMRX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DOCS or IMRX?

IMRX has higher volatility (33.75%) compared to DOCS (29.57%). In terms of maximum drawdown, DOCS dropped -82.35% vs IMRX's -96.86%.

Which has better risk-adjusted returns?

IMRX currently has the higher Sharpe Ratio (0.92 vs -1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.